Skip to main content
Erschienen in: World Journal of Urology 12/2020

Open Access 04.03.2020 | Original Article

Health-related quality of life after open and robot-assisted radical prostatectomy in low- and intermediate-risk prostate cancer patients: a propensity score-matched analysis

verfasst von: Alexander Kretschmer, Robert Bischoff, Michael Chaloupka, Friedrich Jokisch, Thilo Westhofen, Philipp Weinhold, Frank Strittmatter, Armin Becker, Alexander Buchner, Christian G. Stief

Erschienen in: World Journal of Urology | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Introduction of robot-assisted radical prostatectomy (RARP) has revolutionized the therapeutic landscape of organ-confined prostate cancer (PCa). However, comparative analyses focused on health-related quality of life (HRQOL) after RARP and open retropubic prostatectomy (ORP) are sparse.

Methods

In the current retrospective analysis,inclusion criteria encompassed PSA ≤ 10 ng/ml, ≤ pT2c, ISUP ≤ 3, age ≤ 65 years, and preoperative continence. A propensity score-matched patient cohort [n = 418 (ORP: 209, RARP: 209)] was created and HRQOL was prospectively assessed based on validated questionnaires (EORTC QLQ-C30) preoperatively, 3 months, 12 months, and 24 months postoperatively. Primary endpoint was good general HRQOL based on previously published cut-off values. Erectile function was measured via IIEF-5, urinary continence via ICIQ-SF questionnaire. Multivariable analysis included binary logistic regression models (p < 0.05).

Results

Open retropubic prostatectomy and RARP cohorts were well balanced. General HRQOL was significantly higher for ORP compared to RARP after 3 months (70.1 vs. 61.6, p = 0.001), but not at the remaining follow-up time points. There were no significant differences for the remaining QLQ-C30 functioning and symptom scores. In multivariable analysis stratified for IIEF-5 and ICIQ-SF scores and surgeon experience, RARP could be confirmed as a marginally independent predictor for lower ratios of good general HRQOL after 3 months (OR 0.464, 95% CI 0.215–0.999; p = 0.050) without any differences at the remaining time points.

Conclusions

The current study addresses various HRQOL outcomes over a postoperative period of up to 2 years in a homogenous propensity score-matched contemporary cohort. Marginally better general HRQOL outcomes could be detected for ORP compared to RARP 3 months postoperatively.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat The L (2016) Robotic surgery evaluation: 10 years too late. Lancet 388(10049):1026 The L (2016) Robotic surgery evaluation: 10 years too late. Lancet 388(10049):1026
2.
Zurück zum Zitat Coughlin GD, Yaxley JW, Chambers SK, Occhipinti S, Samaratunga H, Zajdlewicz L et al (2018) Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study. Lancet Oncol 19(8):1051–1060CrossRef Coughlin GD, Yaxley JW, Chambers SK, Occhipinti S, Samaratunga H, Zajdlewicz L et al (2018) Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study. Lancet Oncol 19(8):1051–1060CrossRef
3.
Zurück zum Zitat Ilic D, Evans SM, Allan CA, Jung JH, Murphy D, Frydenberg M (2018) Laparoscopic and robot-assisted vs open radical prostatectomy for the treatment of localized prostate cancer: a Cochrane systematic review. BJU Int 121(6):845–853CrossRef Ilic D, Evans SM, Allan CA, Jung JH, Murphy D, Frydenberg M (2018) Laparoscopic and robot-assisted vs open radical prostatectomy for the treatment of localized prostate cancer: a Cochrane systematic review. BJU Int 121(6):845–853CrossRef
4.
Zurück zum Zitat Haese A, Knipper S, Isbarn H, Heinzer H, Tilki D, Salomon G et al (2019) A comparative study of robot-assisted and open radical prostatectomy in 10,790 men treated by highly trained surgeons for both procedures. BJU Int 123:1031–1040CrossRef Haese A, Knipper S, Isbarn H, Heinzer H, Tilki D, Salomon G et al (2019) A comparative study of robot-assisted and open radical prostatectomy in 10,790 men treated by highly trained surgeons for both procedures. BJU Int 123:1031–1040CrossRef
5.
Zurück zum Zitat Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P (2004) ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn 23(4):322–330CrossRef Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P (2004) ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn 23(4):322–330CrossRef
6.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376CrossRef Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376CrossRef
7.
Zurück zum Zitat Snyder CF, Blackford AL, Okuyama T, Akechi T, Yamashita H, Toyama T et al (2013) Using the EORTC-QLQ-C30 in clinical practice for patient management: identifying scores requiring a clinician's attention. Qual Life Res 22(10):2685–2691CrossRef Snyder CF, Blackford AL, Okuyama T, Akechi T, Yamashita H, Toyama T et al (2013) Using the EORTC-QLQ-C30 in clinical practice for patient management: identifying scores requiring a clinician's attention. Qual Life Res 22(10):2685–2691CrossRef
8.
Zurück zum Zitat Kretschmer A, Buchner A, Grabbert M, Sommer A, Herlemann A, Stief CG et al (2017) Perioperative patient education improves long-term satisfaction rates of low-risk prostate cancer patients after radical prostatectomy. World J Urol 35(8):1205–1212CrossRef Kretschmer A, Buchner A, Grabbert M, Sommer A, Herlemann A, Stief CG et al (2017) Perioperative patient education improves long-term satisfaction rates of low-risk prostate cancer patients after radical prostatectomy. World J Urol 35(8):1205–1212CrossRef
9.
Zurück zum Zitat Kretschmer A, Mandel P, Buchner A, Stief CG, Tilki D (2015) Surgical learning curve for open radical prostatectomy: is there an end to the learning curve? World J Urol 33(11):1721–1727CrossRef Kretschmer A, Mandel P, Buchner A, Stief CG, Tilki D (2015) Surgical learning curve for open radical prostatectomy: is there an end to the learning curve? World J Urol 33(11):1721–1727CrossRef
10.
Zurück zum Zitat Rocco B, Gregori A, Stener S, Santoro L, Bozzola A, Galli S et al (2007) Posterior reconstruction of the rhabdosphincter allows a rapid recovery of continence after transperitoneal videolaparoscopic radical prostatectomy. Eur Urol 51(4):996–1003CrossRef Rocco B, Gregori A, Stener S, Santoro L, Bozzola A, Galli S et al (2007) Posterior reconstruction of the rhabdosphincter allows a rapid recovery of continence after transperitoneal videolaparoscopic radical prostatectomy. Eur Urol 51(4):996–1003CrossRef
11.
Zurück zum Zitat Rocco F, Carmignani L, Acquati P, Gadda F, Dell'Orto P, Rocco B et al (2007) Early continence recovery after open radical prostatectomy with restoration of the posterior aspect of the rhabdosphincter. Eur Urol 52(2):376–383CrossRef Rocco F, Carmignani L, Acquati P, Gadda F, Dell'Orto P, Rocco B et al (2007) Early continence recovery after open radical prostatectomy with restoration of the posterior aspect of the rhabdosphincter. Eur Urol 52(2):376–383CrossRef
12.
Zurück zum Zitat Van Velthoven RF, Ahlering TE, Peltier A, Skarecky DW, Clayman RV (2003) Technique for laparoscopic running urethrovesical anastomosis: the single knot method. Urology 61(4):699–702CrossRef Van Velthoven RF, Ahlering TE, Peltier A, Skarecky DW, Clayman RV (2003) Technique for laparoscopic running urethrovesical anastomosis: the single knot method. Urology 61(4):699–702CrossRef
13.
Zurück zum Zitat Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M et al (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71(4):618–629CrossRef Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M et al (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71(4):618–629CrossRef
14.
Zurück zum Zitat Wallerstedt A, Tyritzis SI, Thorsteinsdottir T, Carlsson S, Stranne J, Gustafsson O et al (2015) Short-term results after robot-assisted laparoscopic radical prostatectomy compared to open radical prostatectomy. Eur Urol 67(4):660–670CrossRef Wallerstedt A, Tyritzis SI, Thorsteinsdottir T, Carlsson S, Stranne J, Gustafsson O et al (2015) Short-term results after robot-assisted laparoscopic radical prostatectomy compared to open radical prostatectomy. Eur Urol 67(4):660–670CrossRef
15.
Zurück zum Zitat Haglind E, Carlsson S, Stranne J, Wallerstedt A, Wilderang U, Thorsteinsdottir T et al (2015) Urinary incontinence and erectile dysfunction after robotic versus open radical prostatectomy: a prospective, controlled, nonrandomised trial. Eur Urol 68(2):216–225CrossRef Haglind E, Carlsson S, Stranne J, Wallerstedt A, Wilderang U, Thorsteinsdottir T et al (2015) Urinary incontinence and erectile dysfunction after robotic versus open radical prostatectomy: a prospective, controlled, nonrandomised trial. Eur Urol 68(2):216–225CrossRef
16.
Zurück zum Zitat Herlemann A, Cowan JE, Carroll PR, Cooperberg MR (2018) Community-based outcomes of open versus robot-assisted radical prostatectomy. Eur Urol 73(2):215–223CrossRef Herlemann A, Cowan JE, Carroll PR, Cooperberg MR (2018) Community-based outcomes of open versus robot-assisted radical prostatectomy. Eur Urol 73(2):215–223CrossRef
17.
Zurück zum Zitat Fossati N, Wiklund P, Rochat CH, Montorsi F, Dasgupta P, Sanchez-Salas R et al (2017) Robotic and open radical prostatectomy: the first prospective randomised controlled trial fuels debate rather than closing the question. Eur Urol 71(3):307–308CrossRef Fossati N, Wiklund P, Rochat CH, Montorsi F, Dasgupta P, Sanchez-Salas R et al (2017) Robotic and open radical prostatectomy: the first prospective randomised controlled trial fuels debate rather than closing the question. Eur Urol 71(3):307–308CrossRef
18.
Zurück zum Zitat Martini A, Gandaglia G, Briganti A (2019) What is new in robot-assisted radical prostatectomy: a narrative review. Curr Opin Urol 29(1):14–18CrossRef Martini A, Gandaglia G, Briganti A (2019) What is new in robot-assisted radical prostatectomy: a narrative review. Curr Opin Urol 29(1):14–18CrossRef
19.
Zurück zum Zitat Bravi CA, Tin A, Vertosick E, Mazzone E, Martini A, Dell’Oglio P et al (2019) The impact of experience on the risk of surgical margins and biochemical recurrence after robot-assisted radical prostatectomy: a learning-curve study. J Urol 202:108–113CrossRef Bravi CA, Tin A, Vertosick E, Mazzone E, Martini A, Dell’Oglio P et al (2019) The impact of experience on the risk of surgical margins and biochemical recurrence after robot-assisted radical prostatectomy: a learning-curve study. J Urol 202:108–113CrossRef
20.
21.
Zurück zum Zitat Downing A, Wright P, Hounsome L, Selby P, Wilding S, Watson E et al (2019) Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study. Lancet Oncol 20(3):436–447CrossRef Downing A, Wright P, Hounsome L, Selby P, Wilding S, Watson E et al (2019) Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study. Lancet Oncol 20(3):436–447CrossRef
22.
Zurück zum Zitat Singh V, Yadav R, Sinha RJ, Gupta DK (2014) Prospective comparison of quality-of-life outcomes between ileal conduit urinary diversion and orthotopic neobladder reconstruction after radical cystectomy: a statistical model. BJU Int 113(5):726–732CrossRef Singh V, Yadav R, Sinha RJ, Gupta DK (2014) Prospective comparison of quality-of-life outcomes between ileal conduit urinary diversion and orthotopic neobladder reconstruction after radical cystectomy: a statistical model. BJU Int 113(5):726–732CrossRef
Metadaten
Titel
Health-related quality of life after open and robot-assisted radical prostatectomy in low- and intermediate-risk prostate cancer patients: a propensity score-matched analysis
verfasst von
Alexander Kretschmer
Robert Bischoff
Michael Chaloupka
Friedrich Jokisch
Thilo Westhofen
Philipp Weinhold
Frank Strittmatter
Armin Becker
Alexander Buchner
Christian G. Stief
Publikationsdatum
04.03.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 12/2020
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-020-03144-9

Weitere Artikel der Ausgabe 12/2020

World Journal of Urology 12/2020 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.